請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32076
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江伯倫 | |
dc.contributor.author | Chi-Ling Fu | en |
dc.contributor.author | 傅麒玲 | zh_TW |
dc.date.accessioned | 2021-06-13T03:30:37Z | - |
dc.date.available | 2007-08-04 | |
dc.date.copyright | 2006-08-04 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-28 | |
dc.identifier.citation | Adachi T, M. S., Hirata A, Fukuda T, Kihara N, Makino S (1996). Detection of transforming growth factor-beta in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assay. Clin Exp Allergy 26, 557-562.
Akbari, O., DeKruyff, R. H., and Umetsu, D. T. (2001). Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2, 725-731. Akbari, O., Freeman, G. J., Meyer, E. H., Greenfield, E. A., Chang, T. T., Sharpe, A. H., Berry, G., DeKruyff, R. H., and Umetsu, D. T. (2002). Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 8, 1024-1032. Akdis, C. A., Akdis, M., Blesken, T., Wymann, D., Alkan, S. S., Muller, U., and Blaser, K. (1996). Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 98, 1676-1683. Akdis, C. A., and Blaser, K. (1999). IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. Faseb J 13, 603-609. Akdis, C. A., Blesken, T., Akdis, M., Wuthrich, B., and Blaser, K. (1998). Role of interleukin 10 in specific immunotherapy. J Clin Invest 102, 98-106. Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., Thunberg, S., Deniz, G., Valenta, R., Fiebig, H., et al. (2004). Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199, 1567-1575. Annunziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P., Maggi, E., and Romagnani, S. (2002). Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med 196, 379-387. Asadullah, K., Sterry, W., and Volk, H. D. (2003). Interleukin-10 therapy--review of a new approach. Pharmacol Rev 55, 241-269. Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., and Palucka, K. (2000). Immunobiology of dendritic cells. Annu Rev Immunol 18, 767-811. Barnes, P. J., and Lim, S. (1998). Inhibitory cytokines in asthma. Mol Med Today 4, 452-458. Barnes, P. J. (2000). Endogenous inhibitory mechanisms in asthma. Am J Respir Crit Care Med 161, S176-181. Barnes, P. J. (2002). Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol 42, 81-98. Barnes, P. J. (2001). Cytokine-directed therapies for asthma. J Allergy Clin Immunol 108, S72-76. Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., and O'Garra, A. (2002). In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195, 603-616. Behera, A. K., Kumar, M., Lockey, R. F., and Mohapatra, S. S. (2002). Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum Gene Ther 13, 1697-1709. Belz, G. T., Behrens, G. M., Smith, C. M., Miller, J. F., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., and Heath, W. R. (2002). The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 196, 1099-1104. Bentley, A. M., Meng, Q., Robinson, D. S., Hamid, Q., Kay, A. B., and Durham, S. R. (1993). Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 8, 35-42. Borish, L., Aarons, A., Rumbyrt, J., Cvietusa, P., Negri, J., and Wenzel, S. (1996). Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 97, 1288-1296. Borish, L. (1998). IL-10: evolving concepts. J Allergy Clin Immunol 101, 293-297. Brandes, M. E., Allen, J. B., Ogawa, Y., and Wahl, S. M. (1991). Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 87, 1108-1113. Bromberg, J. S., Boros, P., Ding, Y., Fu, S., Ku, T., Qin, L., and Sung, R. (2002). Gene transfer methods for transplantation. Methods Enzymol 346, 199-224. Bruder, D., Probst-Kepper, M., Westendorf, A. M., Geffers, R., Beissert, S., Loser, K., von Boehmer, H., Buer, J., and Hansen, W. (2004). Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 34, 623-630. Bruselle, G. G., Kips, J. C., Peleman, R. A., Joos, G. F., Devos, R. R., Tavernier, J. H., and Pauwels, R. A. (1997). Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12. Am J Respir Cell Mol Biol 17, 767-771. Burgess, J. K., Carlin, S., Pack, R. A., Arndt, G. M., Au, W. W., Johnson, P. R., Black, J. L., and Hunt, N. H. (2004). Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol 113, 683-689. Busse, W. W. (1998). Leukotrienes and inflammation. Am J Respir Crit Care Med 157, S210-213. Carter, L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., and Carreno, B. M. (2002). PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 32, 634-643. Cavani, A., Nasorri, F., Prezzi, C., Sebastiani, S., Albanesi, C., and Girolomoni, G. (2000). Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 114, 295-302. Chand, N., Harrison, J. E., Rooney, S., Pillar, J., Jakubicki, R., Nolan, K., Diamantis, W., and Sofia, R. D. (1992). Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur J Pharmacol 211, 121-123. Chang, T. C., Kou, S. H., Chen, F. W., Chang, C. C., Liaw, K. Y., Chang-Chien, Y., Huang, T. S., Lin, C. C., and How, S. W. (1982). Cytopathology of thyroid cancer by fine needle aspiration with Liu's stain. Taiwan Yi Xue Hui Za Zhi 81, 1404-1412. Chatenoud, L., Salomon, B., and Bluestone, J. A. (2001). Suppressor T cells--they're back and critical for regulation of autoimmunity! Immunol Rev 182, 149-163. Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., and Bowcock, A. M. (2000). JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106, R75-81. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A., and Weiner, H. L. (1994). Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240. Chiang, D. J., Ye, Y. L., Chen, W. L., Lee, Y. L., Hsu, N. Y., and Chiang, B. L. (2003). Ribavirin or CpG DNA sequence-modulated dendritic cells decrease the IgE level and airway inflammation. Am J Respir Crit Care Med 168, 575-580. Chu, H. W., Trudeau, J. B., Balzar, S., and Wenzel, S. E. (2000). Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 106, 1115-1123. Chuang, Y. H., Fu, C. L., Lo, Y. C., and Chiang, B. L. (2004). Adenovirus expressing Fas ligand gene decreases airway hyper-responsiveness and eosinophilia in a murine model of asthma. Gene Ther 11, 1497-1505. Chuang, Y. H., Suen, J. L., and Chiang, B. L. (2006). Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma. J Mol Med. Chung, K. F., and Barnes, P. J. (1999). Cytokines in asthma. Thorax 54, 825-857. Constant, S. L., Brogdon, J. L., Piggott, D. A., Herrick, C. A., Visintin, I., Ruddle, N. H., and Bottomly, K. (2002). Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest 110, 1441-1448. Constant, S. L., Lee, K. S., and Bottomly, K. (2000). Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation. Eur J Immunol 30, 840-847. Cookson, W. (1999). The alliance of genes and environment in asthma and allergy. Nature 402, B5-11. Corry, D. B., Folkesson, H. G., Warnock, M. L., Erle, D. J., Matthay, M. A., Wiener-Kronish, J. P., and Locksley, R. M. (1996). Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 183, 109-117. Cottrez, F., Hurst, S. D., Coffman, R. L., and Groux, H. (2000). T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 165, 4848-4853. Coyle, A. J., Le Gros, G., Bertrand, C., Tsuyuki, S., Heusser, C. H., Kopf, M., and Anderson, G. P. (1995). Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 13, 54-59. Creticos, P. S., Adkinson, N. F., Jr., Kagey-Sobotka, A., Proud, D., Meier, H. L., Naclerio, R. M., Lichtenstein, L. M., and Norman, P. S. (1985). Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest 76, 2247-2253. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., and Trinchieri, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178, 1041-1048. de Heer, H. J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M. A., Hoogsteden, H. C., and Lambrecht, B. N. (2004). Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 200, 89-98. de Vries, J. E. (1998). The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 102, 165-169. Deguchi, Y. (1992). Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung. Ann Rheum Dis 51, 362-365. Deguchi, Y., and Kishimoto, S. (1991). Spontaneous activation of transforming growth factor-beta gene transcription in broncho-alveolar mononuclear cells of individuals with systemic autoimmune diseases with lung involvement. Lupus 1, 27-30. Demeure, C. E., Yang, L. P., Desjardins, C., Raynauld, P., and Delespesse, G. (1997). Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines. Eur J Immunol 27, 3526-3531. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., and Bhardwaj, N. (2001). Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193, 233-238. Diebold, R. J., Eis, M. J., Yin, M., Ormsby, I., Boivin, G. P., Darrow, B. J., Saffitz, J. E., and Doetschman, T. (1995). Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A 92, 12215-12219. Dow, S. W., Schwarze, J., Heath, T. D., Potter, T. A., and Gelfand, E. W. (1999). Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice. Hum Gene Ther 10, 1905-1914. Egan, R. W., Umland, S. P., Cuss, F. M., and Chapman, R. W. (1996). Biology of interleukin-5 and its relevance to allergic disease. Allergy 51, 71-81. Eisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A., and Bottomly, K. (2002). Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196, 1645-1651. Enk, A. H., Saloga, J., Becker, D., M, B. P. m., and Knop, J. (1994). Induction of hapten-specific tolerance by interleukin 10 in vivo. J Exp Med 179, 1397-1402. Espevik, T., Figari, I. S., Shalaby, M. R., Lackides, G. A., Lewis, G. D., Shepard, H. M., and Palladino, M. A., Jr. (1987). Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med 166, 571-576. Fahy, J. V., Corry, D. B., and Boushey, H. A. (2000). Airway inflammation and remodeling in asthma. Curr Opin Pulm Med 6, 15-20. Faith, A., Akdis, C. A., Akdis, M., Simon, H. U., and Blaser, K. (1997). Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56(lck) and ZAP-70 tyrosine kinase activities. J Immunol 159, 53-60. Fiorentino, D. F., Bond, M. W., and Mosmann, T. R. (1989). Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170, 2081-2095. Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330-336. Fukaura, H., Kent, S. C., Pietrusewicz, M. J., Khoury, S. J., Weiner, H. L., and Hafler, D. A. (1996). Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98, 70-77. Funk, C. D. (2001). Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875. Gavett, S. H., O'Hearn, D. J., Li, X., Huang, S. K., Finkelman, F. D., and Wills-Karp, M. (1995). Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182, 1527-1536. Gershon, R. K., and Kondo, K. (1970). Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723-737. Gilliet, M., and Liu, Y. J. (2002). Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195, 695-704. Gordon, J. R., Li, F., Nayyar, A., Xiang, J., and Zhang, X. (2005). CD8 alpha+, but not CD8 alpha-, dendritic cells tolerize Th2 responses via contact-dependent and -independent mechanisms, and reverse airway hyperresponsiveness, Th2, and eosinophil responses in a mouse model of asthma. J Immunol 175, 1516-1522. Graffi, S. J., Dekan, G., Stingl, G., and Epstein, M. M. (2002). Systemic administration of antigen-pulsed dendritic cells induces experimental allergic asthma in mice upon aerosol antigen rechallenge. Clin Immunol 103, 176-184. Griffiths-Johnson, D. A., Collins, P. D., Rossi, A. G., Jose, P. J., and Williams, T. J. (1993). The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 197, 1167-1172. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., and Roncarolo, M. G. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742. Grunig, G., Corry, D. B., Leach, M. W., Seymour, B. W., Kurup, V. P., and Rennick, D. M. (1997). Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185, 1089-1099. Hamelmann, E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G. L., Irvin, C. G., and Gelfand, E. W. (1997). Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156, 766-775. Hamid, Q. A., and Minshall, E. M. (2000). Molecular pathology of allergic disease: I: lower airway disease. J Allergy Clin Immunol 105, 20-36. Haneda, K., Sano, K., Tamura, G., Sato, T., Habu, S., and Shirato, K. (1997). TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. J Immunol 159, 4484-4490. Haneda, K., Sano, K., Tamura, G., Shirota, H., Ohkawara, Y., Sato, T., Habu, S., and Shirato, K. (1999). Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea. Am J Respir Cell Mol Biol 21, 268-274. Hansen, G., Berry, G., DeKruyff, R. H., and Umetsu, D. T. (1999). Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 103, 175-183. Hansen, G., McIntire, J. J., Yeung, V. P., Berry, G., Thorbecke, G. J., Chen, L., DeKruyff, R. H., and Umetsu, D. T. (2000). CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 105, 61-70. Harizi, H., Juzan, M., Moreau, J. F., and Gualde, N. (2003). Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism. J Immunol 170, 139-146. Havenith, C. E., Breedijk, A. J., Betjes, M. G., Calame, W., Beelen, R. H., and Hoefsmit, E. C. (1993). T cell priming in situ by intratracheally instilled antigen-pulsed dendritic cells. Am J Respir Cell Mol Biol 8, 319-324. Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., and Nussenzweig, M. C. (2001). Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194, 769-779. Herrick, C. A., MacLeod, H., Glusac, E., Tigelaar, R. E., and Bottomly, K. (2000). Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest 105, 765-775. Hobbs, K., Negri, J., Klinnert, M., Rosenwasser, L. J., and Borish, L. (1998). Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 158, 1958-1962. Hofstra, C. L., Van Ark, I., Hofman, G., Kool, M., Nijkamp, F. P., and Van Oosterhout, A. J. (1998). Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J Immunol 161, 5054-5060. Hogan, S. P., Foster, P. S., Tan, X., and Ramsay, A. J. (1998). Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur J Immunol 28, 413-423. Hori, S., and Sakaguchi, S. (2004). Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect 6, 745-751. Horwitz, D. A., Zheng, S. G., and Gray, J. D. (2003). The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets. J Leukoc Biol 74, 471-478. Hsu, C. H., Chua, K. Y., Tao, M. H., Lai, Y. L., Wu, H. D., Huang, S. K., and Hsieh, K. H. (1996). Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med 2, 540-544. Hu, D., Ikizawa, K., Lu, L., Sanchirico, M. E., Shinohara, M. L., and Cantor, H. (2004). Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5, 516-523. Huang, Q., Liu, D., Majewski, P., Schulte, L. C., Korn, J. M., Young, R. A., Lander, E. S., and Hacohen, N. (2001). The plasticity of dendritic cell responses to pathogens and their components. Science 294, 870-875. Huang, S. K., Xiao, H. Q., Kleine-Tebbe, J., Paciotti, G., Marsh, D. G., Lichtenstein, L. M., and Liu, M. C. (1995). IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155, 2688-2694. Huber, S., Schramm, C., Lehr, H. A., Mann, A., Schmitt, S., Becker, C., Protschka, M., Galle, P. R., Neurath, M. F., and Blessing, M. (2004). Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173, 6526-6531. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176, 1693-1702. Jahnsen, F. L., Moloney, E. D., Hogan, T., Upham, J. W., Burke, C. M., and Holt, P. G. (2001). Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 56, 823-826. Jirapongsananuruk, O., and Leung, D. Y. (1997). Clinical applications of cytokines: new directions in the therapy of atopic diseases. Ann Allergy Asthma Immunol 79, 5-16; quiz 19-20. John, M., Lim, S., Seybold, J., Jose, P., Robichaud, A., O'Connor, B., Barnes, P. J., and Chung, K. F. (1998). Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 157, 256-262. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., and Enk, A. H. (2000). Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192, 1213-1222. Jonuleit, H., Schmitt, E., Steinbrink, K., and Enk, A. H. (2001). Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 22, 394-400. Juan, S. H., Lee, T. S., Tseng, K. W., Liou, J. Y., Shyue, S. K., Wu, K. K., and Chau, L. Y. (2001). Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104, 1519-1525. Julia, V., Hessel, E. M., Malherbe, L., Glaichenhaus, N., O'Garra, A., and Coffman, R. L. (2002). A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 16, 271-283. Justice, J. P., Crosby, J., Borchers, M. T., Tomkinson, A., Lee, J. J., and Lee, N. A. (2002). CD4(+) T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. Am J Physiol Lung Cell Mol Physiol 282, L1066-1074. Justice, J. P., Shibata, Y., Sur, S., Mustafa, J., Fan, M., and Van Scott, M. R. (2001). IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol 280, L363-368. Jutel, M., Akdis, M., Budak, F., Aebischer-Casaulta, C., Wrzyszcz, M., Blaser, K., and Akdis, C. A. (2003). IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33, 1205-1214. Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O. A., Malolepszy, J., Zak-Nejmark, T., Koga, R., Kobayashi, T., Blaser, K., and Akdis, C. A. (2001). Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420-425. Kalinski, P., Hilkens, C. M., Snijders, A., Snijdewint, F. G., and Kapsenberg, M. L. (1997). IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 159, 28-35. Kamochi, M., Kamochi, F., Kim, Y. B., Sawh, S., Sanders, J. M., Sarembock, I., Green, S., Young, J. S., Ley, K., Fu, S. M., and Rose, C. E., Jr. (1999). P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. Am J Physiol 277, L310-319. Kanegae, Y., Makimura, M., and Saito, I. (1994). A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47, 157-166. Kay, A. B. (2001). Allergy and allergic diseases. First of two parts. N Engl J Med 344, 30-37. Kim, T. S., DeKruyff, R. H., Rupper, R., Maecker, H. T., Levy, S., and Umetsu, D. T. (1997). An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 158, 4137-4144. Knight, S. C., Mertin, J., Stackpoole, A., and Clark, J. (1983). Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A 80, 6032-6035. Kobayashi, T., Iijima, K., and Kita, H. (2003). Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 170, 5756-5763. Koning, H., Neijens, H. J., Baert, M. R., Oranje, A. P., and Savelkoul, H. F. (1997). T cells subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine 9, 427-436. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274. Kuipers, H., Hijdra, D., De Vries, V. C., Hammad, H., Prins, J. B., Coyle, A. J., Hoogsteden, H. C., and Lambrecht, B. N. (2003). Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. J Immunol 171, 3645-3654. Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A., and Thorbecke, G. J. (1991). Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A 88, 2918-2921. Lamb, J. R., Skidmore, B. J., Green, N., Chiller, J. M., and Feldmann, M. (1983). Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 157, 1434-1447. Lambrecht, B. N., De Veerman, M., Coyle, A. J., Gutierrez-Ramos, J. C., Thielemans, K., and Pauwels, R. A. (2000). Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 106, 551-559. Lambrecht, B. N., and Hammad, H. (2003). Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol 3, 994-1003. Lambrecht, B. N., Salomon, B., Klatzmann, D., and Pauwels, R. A. (1998). Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160, 4090-4097. Larche, M., Robinson, D. S., and Kay, A. B. (2003). The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111, 450-463; quiz 464. Lee, Y. L., Fu, C. L., Ye, Y. L., and Chiang, B. L. (1999). Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation. Scand J Immunol 49, 229-236. Lee, Y. L., Tao, M. H., Chow, Y. H., and Chiang, B. L. (1998). Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy. Hum Gene Ther 9, 457-465. Lee, Y. L., Ye, Y. L., Yu, C. I., Wu, Y. L., Lai, Y. L., Ku, P. H., Hong, R. L., and Chiang, B. L. (2001). Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma. Hum Gene Ther 12, 2065-2079. Letterio, J. J., and Roberts, A. B. (1998). Regulation of immune responses by TGF-beta. Annu Rev Immunol 16, 137-161. Levings, M. K., and Roncarolo, M. G. (2000). T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol 106, S109-112. Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R., and Roncarolo, M. G. (2001). IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166, 5530-5539. Lewis, R. A., Austen, K. F., and Soberman, R. J. (1990). Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323, 645-655. Li, L., Xia, Y., Nguyen, A., Lai, Y. H., Feng, L., Mosmann, T. R., and Lo, D. (1999). Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 162, 2477-2487. Li, X. M., Chopra, R. K., Chou, T. Y., Schofield, B. H., Wills-Karp, M., and Huang, S. K. (1996). Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol 157, 3216-3219. Ling, E. M., Smith, T., Nguyen, X. D., Pridgeon, C., Dallman, M., Arbery, J., Carr, V. A., and Robinson, D. S. (2004). Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363, 608-615. Lloyd, C. M., Gonzalo, J. A., Coyle, A. J., and Gutierrez-Ramos, J. C. (2001). Mouse models of allergic airway disease. Adv Immunol 77, 263-295. Lu, L., Lee, W. C., Takayama, T., Qian, S., Gambotto, A., Robbins, P. D., and Thomson, A. W. (1999). Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig). J Leukoc Biol 66, 293-296. Lukacs, N. W. (2001). Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 1, 108-116. MacKenzie, J. R., Mattes, J., Dent, L. A., and Foster, P. S. (2001). Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J Immunol 167, 3146-3155. Maecker, H. T., Hansen, G., Walter, D. M., DeKruyff, R. H., Levy, S., and Umetsu, D. T. (2001). Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model. J Immunol 166, 959-965. Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H., and Jonuleit, H. (2002). Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 80, 477-483. Makela, M. J., Kanehiro, A., Borish, L., Dakhama, A., Loader, J., Joetham, A., Xing, Z., Jordana, M., Larsen, G. L., and Gelfand, E. W. (2000). IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci U S A 97, 6007-6012. Maloy, K. J., and Powrie, F. (2001). Regulatory T cells in the control of immune pathology. Nat Immunol 2, 816-822. Manavalan, J. S., Kim-Schulze, S., Scotto, L., Naiyer, A. J., Vlad, G., Colombo, P. C., Marboe, C., Mancini, D., Cortesini, R., and Suciu-Foca, N. (2004). Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16, 1055-1068. Mark, D. A., Donovan, C. E., De Sanctis, G. T., He, H. Z., Cernadas, M., Kobzik, L., Perkins, D. L., Sharpe, A., and Finn, P. W. (2000). B7-1 (CD80) and B7-2 (CD86) have complementary roles in mediating allergic pulmonary inflammation and airway hyperresponsiveness. Am J Respir Cell Mol Biol 22, 265-271. Mathur, M., Herrmann, K., Qin, Y., Gulmen, F., Li, X., Krimins, R., Weinstock, J., Elliott, D., Bluestone, J. A., and Padrid, P. (1999). CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice. Am J Respir Cell Mol Biol 21, 498-509. Mattes, J., Yang, M., Mahalingam, S., Kuehr, J., Webb, D. C., Simson, L., Hogan, S. P., Koskinen, A., McKenzie, A. N., Dent, L. A., et al. (2002). Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 195, 1433-1444. Mauser, P. J., Pitman, A. M., Fernandez, X., Foran, S. K., Adams, G. K., 3rd, Kreutner, W., Egan, R. W., and Chapman, R. W. (1995). Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 152, 467-472. McWilliam, A. S., Napoli, | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32076 | - |
dc.description.abstract | 過敏性氣喘肇因於不當的Th2 反應,過敏原專一性 Th2 細胞失控地大量的製造細胞激素,引發肺部發炎反應,嗜酸性白血球聚集,呼吸道黏液大量分泌,氣管劇烈收縮等氣喘症狀。 因此,藉由免疫調節性細胞激素的作用達成抑制過度的 Th2 發炎反應應是合理的治療策略。目前已知 Th1 細胞激素(例如︰ IL-12) 和免疫抑制型細胞激素(例如︰ TGF-β 和 IL-10),都具有降低 Th2 反應並且在調節肺部發炎反應上扮演重要角色。 因此,在本論文中,我們在同一個氣喘動物模式的實驗中,應用四種不同細胞激素(IL-12, IL-10, TGF-β and IL-4) 的DNA 基因質體分別在不同的過敏老鼠身上觀察其對治療氣喘的功效。我們的結果顯示,這些抑制發炎型的細胞激素,特別是 IL-10,可以有效抑制呼吸道的發炎反應。並且,我們也證明這種抑制療效與所給予的細胞激素 DNA 載體的劑量是正相關的。因此,為了 IL-10 基因的表現量與作用時間可以增加,我們進一步的用重組腺病毒載體取代 DNA 質體去評估 IL-10 的抑制效果。如我們所預期,在呼吸道區域表現的 IL-10 是一個可直接抑制過度發炎反應的方法。 然而,更好的治療方法應該是設法增進免疫調節功能去調控 Th2 反應進而能完全治癒過敏性氣喘。 由於,樹突細胞在啟動發炎反應及影響 T 細胞反應發展方向上扮演了舉足輕重的角色; 因此,調控樹突細胞功能會是一個極有潛力的治療策略。於是,接下來我們就藉由DC-IL-10 與 na?ve DO11.10 CD4+ T 細胞的共同培養實驗來評估所培養出來的細胞株之功能分析。結果證明此類細胞株具有類似調節性 T 細胞的功能。總結實驗結果說明了,抑制發炎型的細胞激素 IL-10,不只可以應用在發炎反應部位直接抑制發炎現象,也可以藉由 IL-10 基因改造後的DC 來達成調控免疫反應的治療策略。 | zh_TW |
dc.description.abstract | Allergic asthma strongly correlates with airway inflammation caused by the unregulated production of cytokines secreted by allergen-specific type-2 T helper (Th2) cells. The inappropriate Th2 response causes airway eosinophilic inflammation, mucus hypersecretion and airway hyperreactivity (AHR) result in the symptoms of asthma. The logical resolution of inflammation in the lung occurs through the inhibition of exaggerated Th2-mediated responses by immuno-regulatory cytokines. Both Th1-relatived cytokines, such as IL-12 , and immunosuppressive cytokines, including TGF-β and IL-10, are the candidate cytokines for the treatment of allergic diseases as they downregulate Th2 responses. In current study, we had compared the effect of several cytokines (IL-12, IL-10, TGF-β and IL-4) simultaneously on disease development in a murine model of asthma. Our data demonstrated that anti- inflammatory cytokines, particularly IL-10, have the therapeutic potential for the alleviation of airway inflammation in the asthma model in a dose-dependent manner. Furthermore, in order to achieve high local concentration of IL-10, we used IL-10-expressing adenovirus (Ad-IL-10) to elucidate the therapeutic effect of prolonged homologous IL-10 administration on airway inflammation. As our respect, localized expression of IL-10 may provide a more direct therapeutic approach for diseases of exaggerated proinflammation. However, a more attracting strategy is to enhance immune regulation, which can suppress or modulate Th2 response and cure allergic disease finally. Dendritic cells (DCs) play a crucial role in directing T helper cells differentiation and could be a good candidate of this therapeutic approach. Thus, we had examined whether Ad-IL-10 infected DCs (DC-IL-10) have the potential to induce the differentiation of Tr1-like cells by in vitro repetitive stimulation of na?ve DO11.10 CD4+ T cells with DC-IL-10 and suggest their therapeutic use. Taken together, these results suggested that application of immune-suppressive cytokine, such as IL-10, not only can suppress airway inflammation locally, but also has potential to modulate immune response by genetically modified DCs. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T03:30:37Z (GMT). No. of bitstreams: 1 ntu-95-D89449001-1.pdf: 8544923 bytes, checksum: b249c425f6254a87f0ae393d1223c054 (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | Abstract………………………………………………………………….. i
Abstract in Chinese….…………………………………………………. iii Contents…………………………………………………………………. v List of Figures…………………………………………………………… xi Chapter I. General Introduction…………………………………….. 1 1. An overview of the pathogenesis of asthma…………………. 2 2. How allergens induce and maintain allergy…………………..3 2.1 Sensitization and memory…………………………………..…………….3 2.2 Challenge phase……………………………………………..…………….4 2.3 Late phase response………………………………………..……………..4 3. The pathogenesis of asthma…………………………………….5 3.1 T-helper cells in allergic asthma………………………………………….5 3.2 Th1/Th2 paradigm…………………………………………………….……8 3.3 Immunomodulatory cytokines in asthmatic inflammation………….9 3.3.1 IL-10…………………………………………………..….10 3.3.2 TGF-β…………………………………………………….11 3.4 Role of dendritic cells (DCs) in the sensitization process to inhaled antigen……………………………………………………………….…. 13 3.4.1 Lung dendritic cells preferentially induce Th2 differentiation 15 3.4.2 Lung dendritic cells and tolerance….……………………...16 3.4.3 Dendritic cells as targets for therapy……………………....17 3.4.4 The therapeutic potential of modified DCs ………….….….18 3.4.5 IL-10 expressing dendritic cells………………………..…..19 3.5 T regulatory cells………………………………………………………..….20 3.5.1 Type 1 regulatory cells…………………………………....21 3.5.2 CD4+CD25+TRegcells………………………………….…..22 3.5.3 Th3 cells………………………………….......................23 3.5.4 Other TRegcells…………………………………...............23 3.5.5 Role of regulatory T cells in peripheral T-cell tolerance in the healthy immune response to allergens and allergen-SIT..........................24 4. Interleukin-10…………….……..................................................25 4.1 Biological activities…………………………...........................26 4.2 Interleukin-10 Receptor Signaling…………………………............27 5. Aims of the study………………………….................................. 30 Chapter II. Effects of overexpression of IL-10, IL-12, TGF-β and IL-4 on allergen-induced change in bronchial responsiveness……………….................................... 33 1. Background……………………………............................ 34 2. Materials & Methods……………………………....................... 36 2.1 Animals……………………………......................................................... 36 2.2 Plasmids and preparation of lipid-plasmid DNA complexes …….... 37 2.3 Administration of DNA-lipid complexes……………………………… 38 2.4 Administration of cytokine plasmid into allergen-sensitized mice… 38 2.5 Measurement of airway hyper-responsiveness………..................... 39 2.6 Analysis of bronchoalveolar lavage (BAL) fluid and lung histology. 40 2.7 Eotaxin level in BAL fluid……………………..………………...…….... 41 2.8 Measurement of cytokines……………………………........................ 41 2.9 Quantification of PGE2 and leukotriene B4 (LTB4)………………..... 42 2.10 Statistical analysis……………………………................................. 42 3. Results……………………………............................................. 42 3.1 The effect of different cytokine gene plasmids on methacholine-induced increase in AHR and airway eosinophilia………………..…. 42 3.2 The effect of different cytokine gene plasmids on eotaxin and LTB4 levels in BAL fluid…………………………………………..……. 45 3.3 Dose-dependent effect of IL-10 gene plasmid in the suppression of AHR and airway eosinophilic inflammation in OVA-sensitized mice………………………………………………………………….….. 46 3.4 Combination effect of IL-10 and IL-12 gene plasmids in the suppression of AHR and airway eosinophilic inflammation in OVA-sensitized mice………………………………………………………….. 47 4. Discussion………….……………………………........................ 48 5. Conclusions………………………………................................. 55 Chapter III. Alleviating effects of adenovirus-expressing IL-10 on airway inflammation in a murine model of asthma……………………………............................... 57 1. Introduction…………………………….....................................58 2. Materials and methods……………………………...................59 2.1 Animals……………………………....................................................59 2.2 Recombinant adenovirus construct………………………………..…..59 2.3 Detection of IL-10 in lungs and BAL fluid after the administration of adenoviral vector…………………………………………………… 60 2.4 Sensitization, treatment, and challenge…………………………..…..61 2.5 Measurement of airway hyper-responsiveness…………………..….62 2.6 Collection of BAL fluid and lung histology……………......................62 2.7 Statistical analysis ……………………………....................................62 3. Results…………………………….............................................63 3.1 IL-10 expression in BALF and lung tissues after intra-tracheal delivery of IL-10- expressing adenovirus……....………………..……63 3.2 Intra-tracheal delivery of Ad-IL-10 alleviated the severity of AHR and Ag-induced eosinophilic airway inflammation……………...……63 3.3 The levels of OVA-specific serum antibodies in OVA-sensitized mice after treatment with adenovirus-expressing IL-10 gene……... 65 4. Discussion……………………………………………………….. 65 Chapter IV. Induction of IL 10- producing CD4+ T cells with regulatory properties by repetitive stimulation with IL-10 gene-modified bone marrow derived DCs…………………………………………………….... 71 1. Introduction……………………………………………….. 72 2. Materials and methods…………….…………………………… 73 2.1 Mice……………………………..........................................................73 2.2 Reagents and Abs…………………………….....................................73 2.3 Cell preparations……………………………....................................74 2.3.1 Transduction of bone marrow derived dendritic cells with recombinant adenovirus………………………………………. 74 2.3.2 Isolation and purification of na?ve CD4+ T cells………..……75 2.3.3 Generation of regulatory T cells in vitro ……………….……75 2.4 In vitro stimulating ability of adenovirus infected DCs…………..…76 2.5 Characterization of T cell lines………………………………..………..76 2.5.1 Proliferation and cytokine secreting profiles of T cell lines..76 2.5.2 In vitro suppression assays………………………….77 2.6 Measurement of cytokine production…………………77 2.7 Statistical analysis……………………………....................77 3. Results…………………………….............................................78 3.1 Determination of the optimal ratio of infectious Ad-IL-10 particles to DCs……………………………...........…………………………………….78 3.2 Phenotype of Ad-infected DCs………………………………78 3.3 In vitro stimulatory ability of na?ve CD4+ T cells with adenovirus infected DCs…………………………….................................................79 3.4 Stimulation with DC-IL-10 further enhances the differentiation of IL-10-secreting, Tr1-like T-cells……………………………………………..79 4. Discussion………………………………………………………... 81 Chapter V. Conclusion and Perspectives…………………….... 85 Figures……………………………..............……………………….… 91 References……………………………............................................ 121 Appendix……………………………............................................... 167 | |
dc.language.iso | en | |
dc.title | 探討介白質10基因在治療氣喘動物模式及誘發調節性 T 細胞之能力 | zh_TW |
dc.title | Study on IL-10 gene in the therapeutic effect of murine model of asthma and the induction potential of regulatory T cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 李建國,許秉寧,陶秘華,余俊強 | |
dc.subject.keyword | 氣喘,介白質10,基因治療,調節性 T 細胞,樹突細胞, | zh_TW |
dc.subject.keyword | asthma,interleukin-10,gene therapy,regulatory T cells,dendritic cells, | en |
dc.relation.page | 167 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-07-28 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 免疫學研究所 | zh_TW |
顯示於系所單位: | 免疫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-95-1.pdf 目前未授權公開取用 | 8.34 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。